View Older Stories View More Recent Stories
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G Axovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AmpliPhi Biosciences Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 15 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 11 Filed by: RA CAPITAL MANAGEMENT, LLC
-
PlacementTracker Publishes 2015 PIPE Market League Tables
-
Form SC 13D Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Notable Mergers and Acquisitions 11/19: (PFE)/(AGN) (VHI) (TDG)/(BZC) (CC)/(DOW)
-
Celladon (CLDN), Eiger BioPharma Enter Merger Agreement
-
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
-
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
-
Form 4 Wave Life Sciences Ltd. For: Aug 14 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
-
Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
-
Qvella Raises US$20M in Series A Financing From Leading US and Canadian Venture Funds
-
Form SC 13G Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Oct 19 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
-
Form 4 Aclaris Therapeutics, For: Oct 14 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Oct 07 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Audentes Therapeutics Raises $65 Million in Series C Financing
-
Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Zafgen Announces Transition of Board of Directors
-
Akari Therapeutics Closes $75 Million Private Placement
-
Celsus Therapeutics (CLTX) Closes Acquisition of Volution Immuno Pharma
-
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
-
RA Capital Shows New 9.6% Stake in Aquinox Pharmaceuticals (AQXP)
-
Form SC 13G AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Unusual 11 Mid-Day Movers 8/19: (CLTX) (HILL) (ACI) Higher; (RYAM) (TEDU) (FLXS) Lower
-
WAVE Life Sciences Raises $66 Million in Series B Financing
-
Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement
-
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30


